Search details
1.
Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.
J Allergy Clin Immunol
; 2024 Jun 13.
Article
in English
| MEDLINE | ID: mdl-38878020
2.
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.
N Engl J Med
; 388(2): 183-185, 2023 01 12.
Article
in English
| MEDLINE | ID: mdl-36546661
3.
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
Res Sq
; 2024 Mar 13.
Article
in English
| MEDLINE | ID: mdl-38559048
4.
The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
medRxiv
; 2024 Mar 05.
Article
in English
| MEDLINE | ID: mdl-38496525
5.
Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture.
Sci Rep
; 14(1): 3616, 2024 02 13.
Article
in English
| MEDLINE | ID: mdl-38350990
6.
scRNA-seq profiling of human granulocytes reveals expansion of developmentally flexible neutrophil precursors with mixed neutrophil and eosinophil properties in asthma.
J Leukoc Biol
; 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38814679
7.
Majority of human circulating plasmablasts stop blasting: A probable misnomer.
bioRxiv
; 2023 Sep 13.
Article
in English
| MEDLINE | ID: mdl-37745615
8.
Human Bone Marrow Plasma Cell Atlas: Maturation and Survival Pathways Unraveled by Single Cell Analyses.
bioRxiv
; 2023 Jan 20.
Article
in English
| MEDLINE | ID: mdl-36711623
9.
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.
Cell Rep
; 42(7): 112682, 2023 07 25.
Article
in English
| MEDLINE | ID: mdl-37355988
10.
mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1.
bioRxiv
; 2022 Nov 01.
Article
in English
| MEDLINE | ID: mdl-36380757
Results
1 -
10
de 10
1
Next >
>>